Somaxon Pharmaceuticals Announces $65 Million Financing

Somaxon Pharmaceuticals, a pharmaceutical company focused on developing and marketing products for the treatment of insomnia and other neuro-psychiatric disorders, has announced that it has secured $65 million in committed financing through the private placement of its Series C preferred stock.

()a href="http://biz.yahoo.com/bw/050606/65379.html?.v=1" target="_blank">Yahoo News